Publications
-
PKCĪ²II inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses.
Palaniyandi SS,
Ferreira JC, Brum PC, Mochly-Rosen D.
J Cell Mol Med.
2011;
15
(8):
1769-77
-
Regulation of mitochondrial processes: a target for heart failure.
Palaniyandi SS,
Qi X, Yogalingam G, Ferreira JC, Mochly-Rosen D.
Drug Discov Today Dis Mech.
2010;
7
(2):
e95-e102
-
Protein kinase C in heart failure: a therapeutic target?
Palaniyandi SS,
Sun L, Ferreira JC, Mochly-Rosen D.
Cardiovasc Res.
2009;
82
(2):
229-39
-
14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy.
Thandavarayan RA,
Watanabe K, Ma M, Veeraveedu PT, Gurusamy N, Palaniyandi SS, Zhang S, Muslin AJ, Kodama M, Aizawa Y.
Biochem Pharmacol.
2008;
75
(9):
1797-806
-
Comparative effects of torasemide and furosemide in rats with heart failure.
Veeraveedu PT,
Watanabe K, Ma M, Thandavarayan RA, Palaniyandi SS, Yamaguchi K, Suzuki K, Kodama M, Aizawa Y.
Biochem Pharmacol.
2008;
75
(3):
649-59
-
Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Veeraveedu PT,
Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K, Kodama M, Aizawa Y.
Biochem Pharmacol.
2008;
75
(6):
1322-30
-
Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure.
Palaniyandi SS,
Inagaki K, Mochly-Rosen D.
J Mol Cell Cardiol.
2008;
45
(6):
779-86
-
Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy.
Veeraveedu PT,
Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K, Suzuki K, Kodama M, Aizawa Y.
Eur J Pharmacol.
2008;
581
(1-2):
121-31
-
Blockade of interferon-gamma-inducible protein-10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells.
Suzuki K,
Kawauchi Y, Palaniyandi SS, Veeraveedu PT, Fujii M, Yamagiwa S, Yoneyama H, Han GD, Kawachi H, Okada Y, Ajioka Y, Watanabe K, Hosono M, Asakura H, Aoyagi Y, Narumi S.
Pathol Int.
2007;
57
(7):
413-20
-
Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats.
Palaniyandi SS,
Nagai Y, Watanabe K, Ma M, Veeraveedu PT, Prakash P, Kamal FA, Abe Y, Yamaguchi K, Tachikawa H, Kodama M, Aizawa Y.
Exp Biol Med (Maywood).
2007;
232
(9):
1213-21
-
Effects of nonpeptide vasopressin V2 antagonist tolvaptan in rats with heart failure.
Veeraveedu PT,
Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K, Suzuki K, Kodama M, Aizawa Y.
Biochem Pharmacol.
2007;
74
(10):
1466-75
-
Comparative effects of pranidipine with amlodipine in rats with heart failure.
Veeraveedu PT,
Watanabe K, Ma M, Gurusamy N, Palaniyandi SS, Wen J, Prakash P, Wahed MI, Kamal FA, Mito S, Kunisaki M, Kodama M, Aizawa Y.
Pharmacology.
2006;
77
(1):
1-10
-
Role of IP-10/CXCL10 in the progression of pancreatitis-like injury in mice after murine retroviral infection.
Kawauchi Y,
Suzuki K, Watanabe S, Yamagiwa S, Yoneyama H, Han GD, Palaniyandi SS, Veeraveedu PT, Watanabe K, Kawachi H, Okada Y, Shimizu F, Asakura H, Aoyagi Y, Narumi S.
Am J Physiol Gastrointest Liver Physiol.
2006;
291
(2):
G345-54
-
Inhibition of mast cells by interleukin-10 gene transfer contributes to protection against acute myocarditis in rats.
Palaniyandi SS,
Watanabe K, Ma M, Tachikawa H, Kodama M, Aizawa Y.
Eur J Immunol.
2004;
34
(12):
3508-15
Help